Filing Details

Accession Number:
0001601830-24-000160
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-19 17:48:26
Reporting Period:
2024-09-17
Accepted Time:
2024-09-19 17:48:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1601830 Recursion Pharmaceuticals Inc. RXRX Biological Products, (No Disgnostic Substances) (2836) 464099738
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856094 Blake Borgeson C/O Recursion Pharmaceuticals
41 S. Rio Grande Street
Salt Lake City UT 84101
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2024-09-17 11,447 $6.84 7,109,875 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2023.
  2. This transaction was executed in multiple trades at prices ranging from $6.74 to $7.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.